| Fund ID | 805-7148827750 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 29% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 23% |
| Fund | Type | Gross assets |
|---|---|---|
| Special Situations Fund III Qp, L.P. | Hedge | $528.5M |
| Special Situations Technology Fund II, L.P. | Hedge | $190.9M |
| Special Situations Cayman Fund, L.P. | Hedge | $148.1M |
Life Sciences Innovation Fund II, L.P. reports $8.7 million in gross assets, among the top 79% of private funds by size.
The stated minimum investment is $100,000.
Life Sciences Innovation Fund II, L.P. is managed by Awm Investment Company Inc.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.